Position in GOSS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,926
-$1,081,861 QoQ
Shares Held
132,888
-85.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 168 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. GOSS ranks #129 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in GOSS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,926 | 132,888 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $1,103,787 | 897,388 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $221,886 | 201,715 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $140,003 | 154,700 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $233,287 | 236,600 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,041,768 | 1,156,236 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $213,058 | 180,558 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $337,499 | 369,660 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $299,796 | 359,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $462,480 | 385,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $493,668 | 391,800 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,960,595 | 903,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,549,541 | 129,344 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $316,185 | 37,776 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $829,808 | 95,600 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,385,475 | 122,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,260,771 | 100,300 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $461,593 | 49,902 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $423,952 | 43,842 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||